Gary Ng's most recent trade in Niagen Bioscience Inc. was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Gary Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Gary Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Gary Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Gary Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Gary Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |